The eFlow®rapid nebuliser system with new eBase Controller is suitable for the treatment of a wide range of diseases of the lower airways. It stands for efficient, safe and fast inhalation treatment, combined with even more advantages:
Are you using the blue eBase Controller? Please click here!
[1] Naehrig S et al. Eur J Med Res 2011; 16(2): 63-6
Aerosol characteristics of the eFlow®rapid nebuliser system
| MMADa): | 4,6 µm |
| Respirable Fractiona) < 5 µm: | 55 % |
| Aerosol Output Rateb): | 0,5 g/min |
Aerosol data according to ISO 27427; nebulised medium: Salbutamol 2.5 ml. Measured values may vary depending on the medication used. Recommended fill volume: see package leaflet for the medication.
a) Measurement with Next Generation Pharmaceutical Impactor (NGI) at 23 °C and 50% relative humidity. Inspiratory flow: 15 l/min
b) Measurement with breathing simulator at 23 °C and 50 % relative humidity. 500 ml breathing volume, breathing frequency 15 cycles/minute, sinusoidal breathing pattern, inhalation/exhalation ratio 1:1 (with adults, may vary in children).
For more technical information please see the Instructions for use.
Item No.: WE: 178G1100 – OE: 178G1102
Click on the video links below to find out more about the topics listed. Please always follow the respective instructions for use.
Please note: When you click on a link, you leave our homepage and open a YouTube page. For more information, please see our Privacy Policy.
The eFlow®rapid nebuliser system is designed to administer solutions (such as formulations of colistimethate sodium or (hypertonic) saline solutions) or suspensions for a nebuliser that are approved for the treatment of diseases of the lower airways and for which there is no medication-specific nebuliser handset.
Please note any nebuliser restrictions listed in the package leaflet of the specific solution or suspension.
The controller can be used along with the eFlow®rapid nebuliser handset and for medication-specific eFlow® Technology nebuliser handsets such as Tolero®, Zirela® or Altera®. Please take note of the instructions for use for the medication and nebuliser handset in question.
The inhalation time essentially depends on the medication/inhalation solution and the amount put into the nebuliser. It can become longer over the course of the treatment cycles. How can this happen? Conditions such as water quality or fine dust, for example, can impair the structures of the membrane. To ensure that the powerful technology of the eFlow®rapid nebuliser handset is always at peak performance it must be hygienically reprocessed as per the instructions for use. Consistent cleaning after every use mitigates membrane deterioration, allowing fast inhalation. Daily disinfection of the nebuliser handset and aerosol head also prevents pathogen contamination.
Replace after 3 to 6 months (see also information from the previous question). Please note: If nebulisation time more than doubles, even after using the easycare cleaning aid, the aerosol head needs to be replaced.
Contact your local distributor or service partner:
